Technical Analysis for PODD - Insulet Corporation

Grade Last Price % Change Price Change
grade A 104.08 0.17% 0.18
PODD closed up 0.17 percent on Monday, May 20, 2019, on 39 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical PODD trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 0.17%
Wide Bands Range Expansion 0.17%
Overbought Stochastic Strength 0.17%
Wide Bands Range Expansion -2.00%
Overbought Stochastic Strength -2.00%
Up 3 Days in a Row Strength -2.00%
Wide Bands Range Expansion -0.01%
Overbought Stochastic Strength -0.01%

Older signals for PODD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Insulet Corporation, a medical device company, engages in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.
Medicine Pharmaceuticals Diabetes Endocrine System Healthcare Professionals Diabetes Mellitus Insulin Treatment Of Diabetes Endocrinology Durable Medical Equipment Diabetes Management Insulin Dependent Diabetes Insulin Pump Minimed Paradigm
Is PODD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 108.905
52 Week Low 70.8
Average Volume 662,876
200-Day Moving Average 89.2384
50-Day Moving Average 94.8182
20-Day Moving Average 95.657
10-Day Moving Average 103.645
Average True Range 3.8017
ADX 33.22
+DI 30.4516
-DI 17.4374
Chandelier Exit (Long, 3 ATRs ) 96.3799
Chandelier Exit (Short, 3 ATRs ) 91.83510000000001
Upper Bollinger Band 113.8508
Lower Bollinger Band 77.4632
Percent B (%b) 0.73
BandWidth 38.039663
MACD Line 3.8946
MACD Signal Line 2.9384
MACD Histogram 0.9562
Fundamentals Value
Market Cap 6.04 Billion
Num Shares 58 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -200.15
Price-to-Sales 8.29
Price-to-Book 52.47
PEG Ratio -4.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 111.59
Resistance 3 (R3) 111.47 108.84 110.34
Resistance 2 (R2) 108.84 106.93 108.90 109.92
Resistance 1 (R1) 106.46 105.75 107.65 106.58 109.50
Pivot Point 103.84 103.84 104.43 103.90 103.84
Support 1 (S1) 101.46 101.93 102.65 101.58 98.66
Support 2 (S2) 98.83 100.75 98.89 98.24
Support 3 (S3) 96.45 98.83 97.82
Support 4 (S4) 96.57